SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

BDSX

Biodesix Inc.
NASDAQHealth Care

Latest close: 23.66 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell◇Significant stake declared (13D)●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 12, 2026Reported purchase · Form 4JACK W SCHULER · $367.0KOpen the filing ↗
  2. Aug 11, 2026Reported purchase · Form 4JACK W SCHULER · $328.9KOpen the filing ↗
  3. Aug 10, 2026Reported purchase · Form 4JACK W SCHULER · $337.0KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record54222 flagged findings
Reported transactions (Form 4)80since Jan 2, 2026 · and 5 other holdings
Corporate events (8-K)20since Jan 5, 2021

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC topics

Regulatory history

Topics detected in its SEC reports, with the original excerpt.

Each topic is assigned by a classifier over the full filing; the excerpts show where it was detected and are not always enough to verify it. Open the filing to read it in full.

  • 2026-06-01share offering or dilution eventrecentOpen filing ↗
    “…will attempt to sell the Shares as agent, but may position and resell a portion of the block as principal to facilitate the…”
  • 2026-06-01listing compliance noticerecentOpen filing ↗
    “…product recalls; • legal proceedings initiated by third parties alleging that we are infringing, misappropriating, or otherwise…”
    +1 more passage from the same document
    • “…• future product recalls; • legal proceedings initiated by third parties alleging that we are infringing, misappropriating, or…”
  • 2026-06-01reverse splitrecentOpen filing ↗
    “…conversion or subscription rights and there are no redemption or sinking fund provisions applicable to the common stock.…”
  • 2026-05-21share offering or dilution eventrecentOpen filing ↗
    “…will attempt to sell the Shares as agent, but may position and resell a portion of the block as principal to facilitate the…”
  • 2026-05-21listing compliance noticerecentOpen filing ↗
    “…product recalls; • legal proceedings initiated by third parties alleging that we are infringing, misappropriating, or otherwise…”
    +1 more passage from the same document
    • “…• future product recalls; • legal proceedings initiated by third parties alleging that we are infringing, misappropriating, or…”
  • 2026-05-21reverse splitrecentOpen filing ↗
    “…conversion or subscription rights and there are no redemption or sinking fund provisions applicable to the common stock.…”
  • 2026-05-04share offering or dilution eventrecentOpen filing ↗
    “…offering expenses payable), in gross proceeds from the sale of 1,771,103 common shares at a weighted average price per share of $…”
    +1 more passage from the same document
    • “…common shares at a weighted average price per share of $ 9.72 . The Company had remaining available capacity for share…”
  • 2026-05-04listing compliance noticerecentOpen filing ↗
    “…product recalls; • legal proceedings initiated by third parties alleging that we are infringing, misappropriating, or otherwise…”
    +1 more passage from the same document
    • “…• future product recalls; • legal proceedings initiated by third parties alleging that we are infringing, misappropriating, or…”

1 older entry not shown

Original excerpts from SEC filings, untranslated. Not advice and not a prediction.

Reverse splits in 5 years

1 reverse split in 5 years (1:20 on Sep 15, 2025) · 1:20 cumulative

The other times: of 818 securities that did their first reverse split in 5 years, a year later the median was worth 0.53× the price on the day of the split; 382 lost more than half and 209 rose (809 with a price a year later).

Our own series, not the whole market: based on the splits we have on record (provider and SEC); an unrecorded one does not count. Historical distribution, not a prediction.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 542)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • Aug 5, 2610-Q ↗Quarterly report
  • Aug 5, 268-K ↗Current report · Results
  • Jul 2, 26Form 4 ↗Insider transaction
  • Jun 18, 26SCHEDULE 13G ↗Passive stake · Soleus Capital Master Fund, L.P. · 5.1% · event on Jun 17, 26
  • Jun 1, 26424B3 ↗Securities offering
  • May 27, 26CORRESP ↗Correspondence with the SEC
  • May 26, 26UPLOAD ↗Correspondence with the SEC
  • May 21, 26S-3 ↗Securities offering
  • May 20, 268-K ↗Current report · Shareholder vote results
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · Perceptive Advisors LLC · 4.6% · event on Mar 31, 26 · amendment
  • May 8, 26SCHEDULE 13G/A ↗Passive stake · Soleus Capital Master Fund, L.P. · 4.1% · event on Mar 31, 26 · amendment
  • May 4, 2610-Q ↗Quarterly report
  • May 4, 268-K ↗Current report · Results
  • Apr 28, 26SCHEDULE 13G ↗Passive stake · Orin Hirschman · 7.7% · event on Mar 31, 26
  • Apr 9, 26DEFA14A ↗Shareholder meeting and votes
  • Apr 9, 26DEF 14A ↗Shareholder meeting and votes
  • Apr 2, 26Form 4 ↗Insider transaction
  • Feb 26, 2610-K ↗Annual report
  • Feb 26, 268-K ↗Current report · Results
  • Feb 23, 26Form 144 ↗Notice of proposed sale
  • Insider transaction · 2 Form 4 filingsshow all 2hide

542 filings on record, the oldest from Sep 10, 20.

Listing the 25 most recent filings of the 542 on record.

8-Ks, explained

Stress1Structure14Governance5
  • Apr 17, 25GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Mar 28, 25StressListing notice (8-K 3.01)8-K 3.01 ↗
  • Apr 9, 24StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Dec 20, 23StructureTook on a new financial obligation+1 more in the same filing8-K 2.03 ↗
  • Jun 6, 23GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Dec 16, 22GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Structure4 material agreements entered2022show all 4hide
    • Nov 21, 22StructureEntered a material agreement+5 more in the same filing8-K 1.01 ↗
    • Apr 11, 22StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Mar 7, 22StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
    • Jan 4, 22StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Dec 8, 21GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Mar 23, 21StructureEntered a material agreement+4 more in the same filing8-K 1.01 ↗
  • Jan 5, 21GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13D: stake and stated purpose

Filed by holders above 5% of a share class who cannot use the short form. It includes the investor's stated purpose: read it before assuming they seek influence.

  • SCHULER JACK W24.0%Jan 23, 26SCHEDULE 13D/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Orin Hirschman7.7%Mar 31, 26SCHEDULE 13G ↗2 co-filers on this document — the figure is the largest single stake, not their sum.
  • Telemark Asset Management, LLC5.4%Jan 22, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • Soleus Capital Master Fund, L.P.5.1%Jun 17, 26SCHEDULE 13G ↗6 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings
  • Perceptive Advisors LLC4.6%Mar 31, 26SCHEDULE 13G/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum. · 2 earlier filings

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 12, 26Buy$367KJACK W SCHULER↗
  • Aug 11, 26Buy$329KJACK W SCHULER↗
  • Aug 10, 26Buy$337KJACK W SCHULER↗
  • Feb 23, 26Sell$7KKieran O'KaneChief Commercial Officer↗
  • Feb 23, 26Sell$7KGary Anthony PestanoChief Development Officer↗
  • Feb 23, 26Sell$19KScott HuttonPresident & CEO↗
  • Feb 23, 26Sell$7KRobin Harper CowieCFO, Sec'y & Treasurer↗
  • Feb 23, 26Sell$3KChris VazquezChief Accounting Officer↗
  • Feb 10, 26Sell$36KScott HuttonPresident & CEO↗
  • Feb 10, 26Sell$5KGary Anthony PestanoChief Development Officer↗
  • Feb 10, 26Sell$6KKieran O'KaneChief Commercial Officer↗
  • Feb 10, 26Sell$1KChris VazquezChief Accounting Officer↗

There are 9 more transactions in this stretch.

Stock compensation, tax and giftsshow the 19 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 30, 26Compensationamount n/aJOHN PATIENCE↗
  • Jun 30, 26Compensationamount n/aJOHN PATIENCE↗
  • Mar 31, 26Compensationamount n/aJOHN PATIENCE↗
  • Feb 20, 26Compensationamount n/aKieran O'KaneChief Commercial Officer↗
  • Feb 20, 26Compensationamount n/aGary Anthony PestanoChief Development Officer↗
  • Feb 20, 26Compensationamount n/aScott HuttonPresident & CEO↗
  • Feb 20, 26Compensationamount n/aRobin Harper CowieCFO, Sec'y & Treasurer↗
  • Feb 20, 26Compensationamount n/aChris VazquezChief Accounting Officer↗
  • Feb 9, 26Compensationamount n/aScott HuttonPresident & CEO↗
  • Feb 9, 26Compensationamount n/aGary Anthony PestanoChief Development Officer↗
  • Feb 9, 26Compensationamount n/aKieran O'KaneChief Commercial Officer↗
  • Feb 9, 26Compensationamount n/aChris VazquezChief Accounting Officer↗
  • Feb 9, 26Compensationamount n/aRobin Harper CowieCFO, Sec'y & Treasurer↗
  • Jan 15, 26Compensationamount n/aRobin Harper CowieCFO, Sec'y & Treasurer↗
  • Jan 15, 26Compensationamount n/aScott HuttonPresident & CEO↗
  • Jan 15, 26Compensationamount n/aKieran O'KaneChief Commercial Officer↗
  • Jan 15, 26Compensationamount n/aGary Anthony PestanoChief Development Officer↗
  • Jan 15, 26Compensationamount n/aChris VazquezChief Accounting Officer↗
  • Jan 5, 26Compensationamount n/aJOHN PATIENCE↗

The full record holds 264 transactions and goes back to Feb 23, 21.

Its sector and its market

Biodesix Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Biodesix Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Biodesix Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
542 documents on file, from Sep 10, 2020 to Oct 2, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.